Cause of death, by non-communicable diseases, ages 0-4, female in Myanmar
Myanmar: Cause of death, by non-communicable diseases, ages 0-4, female was 13.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Myanmar, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, female in Myanmar stood at 13.2%.
That represents a change of down 16.4% on the previous year and up 10.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Myanmar peaked at 15.8% in 2020 and was at its lowest, 9.9%, in 2000.
That places Myanmar 136th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, female in Myanmar, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 9.9% | — |
| 2010 | 12.0% | +20.7% |
| 2015 | 13.6% | +13.9% |
| 2019 | 15.1% | +10.7% |
| 2020 | 15.8% | +4.7% |
| 2021 | 13.2% | -16.4% |
Myanmar compared with similar countries
- Myanmar's 13.2% is above the median for lower middle income countries, which is 12.1%, 1.1× the median. (47 countries reporting)
- Myanmar's 13.2% is below the median for East Asia & Pacific, which is 30.9%, 43% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.9% | 9.9% | 9.9% | 1 |
| 2010s | 13.5% | 12.0% | 15.1% | 3 |
| 2020s | 14.5% | 13.2% | 15.8% | 2 |
Countries ranked near Myanmar
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate -0.759 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0387 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8351 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Myanmar?
- Cause of death, by non-communicable diseases, ages 0-4, female in Myanmar was 13.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Myanmar?
- The highest recorded value was 15.8% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Myanmar?
- The lowest recorded value was 9.9% in 2000.
- How does Myanmar rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Myanmar ranks 136th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Myanmar?
- Over the last ten years it is up 10.3%. The long-run trend across the full record is rising.
- Where does this Myanmar data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.